We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$38.4B
1-Year Est. Return
25.71%
This Fund
S&P 500
This Quarter
Est. Return
+8.67%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$23B
AUM Growth
+$1.22B
(+5.6%)
Cap. Flow
-$156M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
22.7%
Holding
1,905
New
81
Increased
568
Reduced
855
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pool Corp
POOL
|
+$43.2M |
| 2 |
Atlassian
TEAM
|
+$36.6M |
| 3 |
Novanta
NOVT
|
+$28.8M |
| 4 |
Palo Alto Networks
PANW
|
+$23.2M |
| 5 |
Motorola Solutions
MSI
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$103M |
| 2 |
PayPal
PYPL
|
+$28.4M |
| 3 |
Walt Disney
DIS
|
+$26.7M |
| 4 |
CarMax
KMX
|
+$25.2M |
| 5 |
Salesforce
CRM
|
+$24.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.31% |
| 2 | Healthcare | 19.82% |
| 3 | Financials | 12.49% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 8.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
1251
DELISTED
NEVRO CORP.
NVRO
| $279K | ﹤0.01% |
7,045
-23,903
| -77% | -$994K |
|
1252
Blue Owl Capital
OBDC
$5.87B
| $278K | ﹤0.01% |
24,112
+151
| +0.6% | +$1.81K |
|
1253
Spotify
SPOT
$102B
| $278K | ﹤0.01% |
3,527
+23
| +0.7% | +$1.85K |
|
1254
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.01B
| $278K | ﹤0.01% |
6,939
-1,451
| -17% | -$58.2K |
|
|
NXRT
1255
NexPoint Residential Trust
NXRT
$641M
| $275K | ﹤0.01% |
6,330
-1,580
| -20% | -$70.6K |
|
1256
ProShares Short S&P500
SH
$839M
| $275K | ﹤0.01% |
4,294
-1,298
| -23% | -$83.2K |
|
1257
Liberty Global Class C
LBTYK
$3.44B
| $275K | ﹤0.01% |
14,149
| – | – |
|
1258
iShares China Large-Cap ETF
FXI
$4.15B
| $275K | ﹤0.01% |
9,704
| – | – |
|
1259
MKS Inc
MKSI
$21.2B
| $273K | ﹤0.01% |
3,221
-183
| -5% | -$14.7K |
|
1260
GameStop
GME
$8.31B
| $272K | ﹤0.01% |
14,761
-267
| -2% | -$6.55K |
|
1261
First Busey Corp
BUSE
$2.59B
| $272K | ﹤0.01% |
11,000
| – | – |
|
1262
Idacorp
IDA
$8.15B
| $271K | ﹤0.01% |
2,515
-116
| -4% | -$12K |
|
|
SRCL
1263
DELISTED
Stericycle Inc
SRCL
| $271K | ﹤0.01% |
5,422
-17
| -0.3% | -$809 |
|
1264
Traeger
COOK
$170M
| $269K | ﹤0.01% |
1,909
-429
| -18% | -$71.7K |
|
1265
ImmunityBio
IBRX
$8.14B
| $269K | ﹤0.01% |
53,031
-500
| -0.9% | -$2.75K |
|
|
TWOU
1266
DELISTED
2U Inc
TWOU
| $268K | ﹤0.01% |
1,423
-7,529
| -84% | -$1.49M |
|
1267
U-Haul Holding Co Series N
UHAL.B
$12.7B
| $268K | ﹤0.01% |
+4,869
| New | +$282K |
|
1268
ManpowerGroup
MAN
$2.65B
| $268K | ﹤0.01% |
3,215
-467
| -13% | -$37.5K |
|
1269
Synchrony
SYF
$26.1B
| $267K | ﹤0.01% |
8,118
-120
| -1% | -$4.11K |
|
1270
iShares US Telecommunications ETF
IYZ
$1.24B
| $266K | ﹤0.01% |
11,854
-735
| -6% | -$16.4K |
|
1271
Thomson Reuters
TRI
$44.5B
| $266K | ﹤0.01% |
2,212
+1
| +0% | +$115 |
|
1272
Invesco Variable Rate Preferred ETF
VRP
$3.01B
| $262K | ﹤0.01% |
11,712
-885
| -7% | -$19.6K |
|
1273
Crocs
CROX
$6.31B
| $262K | ﹤0.01% |
+2,414
| New | +$214K |
|
1274
UFP Industries
UFPI
$5.04B
| $261K | ﹤0.01% |
3,299
-37
| -1% | -$2.83K |
|
1275
Hormel Foods
HRL
$13.5B
| $260K | ﹤0.01% |
5,711
+30
| +0.5% | +$1.4K |
|
Similar funds
HF
William Blair & Company's Q4 2022 Portfolio in Review
As of Q4 2022, William Blair & Company held 1,905 positions worth $23B, up 5.6% from $21.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
William Blair & Company's Q4 2022 filing shows 81 new, 568 increased, 855 reduced and 91 closed positions. Its largest new stake was Atlassian: 230,078 shares worth $29.6M. The largest sale was Abiomed Inc, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- William Blair & Company's largest Q4 2022 buy was Atlassian: 230,078 shares worth $29.6M.
- William Blair & Company added most to Pool Corp in Q4 2022, an estimated $43.2M increase.
- William Blair & Company's biggest Q4 2022 reduction was PayPal, cutting an estimated $28.4M.
- William Blair & Company fully exited Abiomed Inc in Q4 2022, selling an estimated $103M.
- William Blair & Company's ten largest holdings make up 23% of its $23B portfolio in Q4 2022.
- William Blair & Company opened 81 new positions and closed 91 in Q4 2022.
- William Blair & Company's portfolio value rose 5.6% quarter-over-quarter to $23B.
Based on William Blair & Company's 13F filing for Q4 2022, filed 10 Feb 2023.